» Articles » PMID: 30565830

The Relationship Between Mesorectal Grading and Oncological Outcome in Rectal Adenocarcinoma

Overview
Journal Colorectal Dis
Specialty Gastroenterology
Date 2018 Dec 20
PMID 30565830
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: The prognostic association between mesorectal grading and oncological outcome in patients undergoing resection for rectal adenocarcinoma is controversial. The aim of this retrospective chart review was to determine the individual impact of mesorectal grading on rectal cancer outcomes.

Method: We compared oncological outcomes in patients with complete, near-complete and incomplete mesorectum who underwent rectal excision with curative intent from 2009 to 2014 for Stage cI-III rectal adenocarcinoma. We also assessed the independent association of mesorectal grading and oncological outcome using multivariate models including other relevant variables.

Results: Out of 505 patients (339 men, median age of 60 years), 347 (69%) underwent a restorative procedure. There were 452 (89.5%), 33 (6.5%) and 20 (4%) patients with a complete, near-complete and incomplete mesorectum, respectively. Local recurrence was seen in 2.4% (n = 12) patients after a mean follow-up of 3.1 ± 1.7 years. Unadjusted 3-year Kaplan-Meier analysis by mesorectal grade showed decreased rates of overall, disease-free and cancer-specific survival and increased rates of overall and distant recurrence with a near-complete mesorectum, while local recurrence was increased in cases of an incomplete mesorectum (all P < 0.05). On multivariate analyses, a near-complete mesorectum was independently associated with decreased cancer-specific survival (hazard ratio 0.26, 95% CI 0.1-0.7; P = 0.007). There were no associations between mesorectal grading and overall survival, disease-free survival, overall recurrence or distant recurrence (all P > 0.05).

Conclusion: Mesorectal grading is independently associated with oncological outcome. It provides unique information for optimizing surgical quality in rectal cancer.

Citing Articles

Total mesorectal excision quality in rectal cancer surgery affects local recurrence rate but not distant recurrence and survival: population-based cohort study.

Collin A, Dahlback C, Folkesson J, Buchwald P BJS Open. 2024; 8(4).

PMID: 39113260 PMC: 11306320. DOI: 10.1093/bjsopen/zrae071.


Lower conversion rate with robotic assisted rectal resections compared with conventional laparoscopy; a national cohort study.

Myrseth E, Nymo L, Gjessing P, Korner H, Kvaloy J, Norderval S Surg Endosc. 2021; 36(5):3574-3584.

PMID: 34406469 PMC: 9001201. DOI: 10.1007/s00464-021-08681-x.


Adjuvant therapy in patients with rectal adenocarcinoma treated with neoadjuvant chemoradiotherapy and radical resection in pathological stages I-III.

Lino-Silva L, Zepeda-Najar C, Salcedo-Hernandez R Ann Transl Med. 2020; 8(17):1116.

PMID: 33145335 PMC: 7575958. DOI: 10.21037/atm-20-5088.